Keywords: Amgen, Prolia, FDA, USA, Osteoporosis
Another boost for Amgen as US FDA approves injectable osteoporosis drug Prolia, with peak sales expectations of as much as $6 billion
Article | 02 June 2010
There was good news for US biotechnology major Amgen yesterday, when the Food and Drug Administration approved the firm’s ...
Enjoying this article? To continue reading you need to login or subscribe.